Here’s an HTML representation of information regarding Talon Therapeutics and Yahoo Finance, aiming for a concise and informative summary within a 500-word limit: “`html

Talon Therapeutics and Yahoo Finance: A Brief Overview

Talon Therapeutics, Inc. (OTCQB: TLON) is a biopharmaceutical company that historically focused on developing and commercializing cancer therapies. Its story involves both promise and setbacks, particularly concerning its key drug candidate, Marqibo.

Marqibo and Business Focus

Marqibo (vincristine sulfate liposome injection) was Talon’s primary focus. It’s a formulation of vincristine designed to improve its delivery to cancer cells. It received FDA approval for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse, or whose disease has progressed following two or more prior lines of therapy. However, despite the approval, Marqibo’s commercial success was limited.

Over time, Talon faced financial challenges, influencing its operational decisions. In more recent filings, the company has discussed strategic alternatives to maximize shareholder value, including potential mergers, acquisitions, or asset sales. The company’s activities have significantly decreased in scope from its initial goals.

Yahoo Finance and TLON Stock

Yahoo Finance is a widely used platform for tracking financial data, including stock prices, news, and company information. Talon Therapeutics, trading under the ticker symbol TLON on the OTCQB market, is covered on Yahoo Finance.

On Yahoo Finance, users can find information about TLON’s stock price, historical performance, key statistics (market cap, volume, etc.), analyst estimates (though coverage may be limited given the company’s size and status), and relevant news articles. However, it’s crucial to remember that information on Yahoo Finance, while generally reliable, is for informational purposes and should not be considered financial advice. Due diligence is always required before making investment decisions.

Important Considerations

Investing in smaller, over-the-counter (OTC) stocks like TLON carries significant risk. These stocks often experience higher volatility, lower trading volumes, and less stringent regulatory oversight compared to stocks listed on major exchanges like the NYSE or NASDAQ. Financial information for OTC-listed companies may also be less readily available or less comprehensive.

Before considering an investment in Talon Therapeutics, or any similar company, it’s essential to thoroughly research the company’s financial statements, business prospects, and potential risks. Pay close attention to their cash position, ongoing expenses, and any future plans outlined in their SEC filings.

In Conclusion

Talon Therapeutics presents a complex situation. While it had an approved product in Marqibo, its commercial performance and the company’s financial health have been challenging. Yahoo Finance provides a convenient way to track TLON’s stock information, but thorough independent research and a careful assessment of risk are paramount before investing.

“`